U.S. FDA, Industry Aim to Further Strengthen Pharma Supply Chain Quality
This article was originally published in PharmAsia News
Executive Summary
While the pharmaceutical industry and U.S. FDA have made progress in better controlling the pharmaceutical supply chain since the heparin crisis a few years ago, they recognize that more needs to be done, said FDA and industry officials at a recent PDA/FDA Pharmaceutical Supply Chain Workshop in Bethesda, Md